New Directions in Biology and Disease of Skeletal Muscle 2022

Back

FORCE™ Platform for Targeted Delivery of Oligonucleotide Therapeutics for Muscle Diseases (presentation)

View

©2026 Dyne Therapeutics, Inc. All rights reserved MED-00978. Date of preparation: July 2026.